One important metric to look for in a stock is an 80 or higher Relative Strength Rating. CME Group Cl A just hit that mark, with a jump from 78 to 82 Thursday.
Hone Your Stock-Picking Skills By Focusing On These Factors
IBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks matches up against that of all other stocks.
History shows that the best stocks often have an RS Rating north of 80 as they launch their biggest climbs.
CME Group Cl A is working on a flat base with a 290.79 entry. See if the stock can break out in volume at least 40% higher than normal.
The company saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 6% to 12%. Revenue rose from 6% to 10%. The next quarterly numbers are expected on or around Jul. 23.
CME Group Cl A holds the No. 10 rank among its peers in the Financial Services-Specialty industry group. Jiayin Group ADR, X Financial ADR and IREN are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
